At PDCI Market Access Inc., our vision at PDCI is to be your most trusted and valued pricing and reimbursement strategic partner. To ensure we continue to meet the strategic needs of our customers in the face of the ever-changing Canadian reimbursement landscape, we’ve expanded our Health Economic and Pricing teams.
We’re excited and proud to introduce you to newest members of the PDCI team.
Health Economist – Nicolas Iragorri, PhD (in progress), Health Services Research – Health Technology Assessment, University of Toronto; MSc, Health Economics, University of Calgary
- Nicolas joins PDCI as a Health Economist and HTA Associate. Nicolas has experience developing economic evaluations, systematic literature reviews and meta-analyses, and other qualitative and quantitative analyses for health technologies in Canada. Over the past year, Nicolas worked with the Canadian Partnership Against Cancer (CPAC) leading economic analyses that helped to inform, advise, and support priority setting and decision making for the organization.
Health Economics Analyst – Shabna Mohideen, MSc, Physiology and Pharmacology, University of Western Ontario.
- Shabna joins PDCI as Analyst, HTA & Health Economics. Her experience includes working in a global consulting firm supporting a variety of market access projects including systematic and targeted literature reviews, global value dossiers, HTA submissions, and landscape assessments for the pharmaceutical and biotechnology industry.
Pricing, Data Analytics, and Modeling Associate– Mevin Mathew, MBA (Pharmaceutical Management), National Institute for Pharmaceutical Education and Research, India; Bachelor of Pharmacy, University of Mumbai, India
- Mevin joins PDCI as Associate, Pricing and Data Analytics. Mevin is a pharmacist and holds an MBA, with a specialization in pharmaceutical company management. He has training and experience in submissions, health economics and modeling, as well as pricing research, and data analytics. Notably, he has held positions with global consulting firms where he was responsible for updating global pricing databases and supporting development of de novo cost-effectiveness models.
Please join us in welcoming Nicolas, Shabna, and Mevin to the team!